Delaware Valley Retina Associates joins the PRISM Vision Group platform
NEW PROVIDENCE, NJ / ACCESSWIRE / January 11, 2024 / PRISM Vision Group® (PVG), the largest vertically integrated eye care services organization operating exclusively on the East Coast, celebrates the addition of Delaware Valley Retina Associates (DVRA) to its growing platform. DVRA was founded in 1985 and has built a reputation for providing exceptional patient care in diagnosing and treating a comprehensive range of retinal disorders with five locations that serve New Jersey and Pennsylvania.
“We are thrilled to welcome the entire DVRA team to PRISM,” stated Steven Madreperla, M.D., PhD., President and CEO of PRISM Vision Group; he continued “their commitment to high-quality clinical care combined with their focus on the patient experience made DVRA a natural partner for PRISM as we progress in our journey to be America’s premier independent eye care organization today, and 100 years from now.”
To learn more about PRISM Vision Group, please visit: www.prismvisiongroup.com To learn more about Delaware Valley Retina Associates, please visit: www.dvra.net
About PRISM Vision Group®
PRISM Vision Group® is the largest vertically integrated independent ophthalmology administrative services organization (ASO) operating exclusively on the East Coast. PRISM provides eye care in 91 locations, with 177 providers, 6 Ambulatory Surgery Centers, and over 1300 employees throughout New Jersey, Pennsylvania, Delaware, Virginia, Maryland, and the District of Columbia. PRISM Vision Group is a physician-led organization with a mission to support practices in providing patients with world-class, comprehensive eye care in an unrivaled practice environment for its network of affiliated physicians and employees.
Contact Information
Jennifer Shinners
VP Communications
jshinners@prismvisiongroup.com
6176783031
SOURCE: PRISM Vision Group
View the original press release on newswire.com.
- Revenue increase of over 600%Dallas, Georgia--(Newsfile Corp. - July 2, 2024) - Bemax Inc.…
VANCOUVER, BC / ACCESSWIRE / July 2, 2024 / 1933 Industries Inc. (the "Company" or…
CAMBRIDGE, MA / ACCESSWIRE / July 2, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced a…
SALT LAKE CITY, July 02, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a…
The ceremony will be held in celebration of Scilex’s launch of GLOPERBA®, an innovative non-opioid…
July 2, 2024 Biodexa Pharmaceuticals PLC Positive Phase 1 Clinical Data of MTX110 in DMG…